| Abbreviations | Meaning |
 | MPL | Maximum Permissible Level; Melphalan; Mesiopulpolingual; Myeloproliferative Leukemia |
| CGL | Chronic Granulocytic Leukemia; Clinical Guidelines |
| TNFB | Tumor Necrosis Factor Beta |
| GX | Glycinexylidide; Histopathologic Grade Of Tumor Cannot Be Assessed [TNM (tumor-node-metastasis) Classification] |
| KIN | Keratinocytic Intraepidermal Neoplasia |
| CKS | Classic Form Of Kaposi Sarcoma |
| PLCC | Primary Liver Cell Cancer |
| VIPOMA | Vasoactive Intestinal Polypeptide-secreting Tumor |
| LCEA | Lung Carcinoma Expressed Antigens |
| ACC | Alveolar Cell Carcinoma |
| CFTC | Complication-free Tumor Control |
| AML | Acute Myelocytic Leukemia |
| ICR | Institute For Cancer Research |
| PT | Pertussis Toxin; Postoperative Tumor Size [TNM (tumor-node-metastasis) Classification: PT0 Surgery Not Done Or Not Applicable, PT1 No Visible Tumor Tissue, PT2 Less Than 1.5 Cm Remains, PT3 1.5 To 5.0 Cm Remains, PT4 More Than 5.0 Cm Remains To Primary Tumors In Progressing Thickness, And PTX No Evidence Of Primary Tumor] |
| LATU | Lobulo-alveolar Tumor |
Browse by Letter:
